Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AXITINIB vs AZILSARTAN KAMEDOXOMIL\CHLORTHALIDONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AXITINIB vs AZILSARTAN KAMEDOXOMIL\CHLORTHALIDONE: Safety Overview

Metric AXITINIB AZILSARTAN KAMEDOXOMIL\CHLORTHALIDONE
Total FAERS Reports 15,863 766
Deaths Reported 3,141 18
Death Rate 19.8% 2.3%
Hospitalizations 4,050 77
Average Patient Age 65.5 yrs 62.1 yrs
% Female Patients 29.4% 54.3%
FDA Approval Date Jan 27, 2012 N/A
Manufacturer Pfizer Laboratories Div Pfizer Inc N/A
Route ORAL N/A
Marketing Status Prescription N/A